
ADMA Biologics Shareholders Face August Deadline in Securities Lawsuit
Investors who lost more than $100,000 in ADMA Biologics stock between August 2024 and March 2026 have until August 10 to file for lead plaintiff status. The class action lawsuit, currently pending in the U.S. District Court for the District of New Jersey, targets alleged federal securities law violations.






















